This guideline covers diagnosing, assessing and managing primary hyperparathyroidism. It aims to
improve recognition and treatment of this condition, reducing long-term complications and
improving quality of life....
This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD
(which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help
people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce
symptoms, improve q...
This guideline covers recognising, assessing and treating bipolar disorder (formerly known as manic depression) in children, young people and adults. The recommendations apply to bipolar I, bipolar II, mixed affective and rapid cycling disorders. It aims to improve access to treatment and quality of life...
This guideline covers managing neuropathic pain (nerve pain) with pharmacological treatments (drugs) in adults in non-specialist settings. It aims to improve quality of life for people with conditions such as neuralgia, shingles and diabetic neuropathy by reducing pain and promoting increased participati...
OBJECTIVES: When conservative therapies such as pain medication or exercise therapy fail, invasive treatment may be indicated for patients with lumbosacral spinal pain. The Dutch Society of Anesthesiologists, in collaboration with the Dutch Orthopedic Association and the Dutch Neurosurgical Society, has ...
La guía tiene por objetivo ofrecer a los profesionales implicados en el manejo de la artroplastia de rodilla un conjunto de recomendaciones basadas en la mejor evidencia científica disponible, como herramienta de ayuda a la toma de decisiones, con el fin último de optimizar los resultados en salud, di...
Brożek, J. L;
Bousquet, J;
Agache, I;
Agarwal, A;
Bachert, C;
Bosnic-Anticevich, S;
Brignardello-Petersen, R;
Canonica, G. W;
Casale, T;
Chavannes, N. H;
Correia de Sousa, J;
Cruz, A. A;
Cuello-Garcia, C. A;
Demoly, P;
Dykewicz, M;
Etxeandia-Ikobaltzeta, I;
Florez, I. D;
Fokkens, W;
Fonseca, J;
Hellings, P. W;
Klimek, L;
Kowalski, S;
Kuna, P;
Laisaar, K. T;
Larenas-Linnemann, D. E;
Lodrup Carlsen, K. C;
Manning, P. J;
Meltzer, E;
Mullol, J;
Muraro, A;
O'Hehir, R;
Ohta, K;
Panzner, P;
Panzner, P;
Papadopoulos, N;
Park, H. S;
Passalacqua, G;
Pawankar, R;
Price, D;
Riva, J. J;
Roldán, Y;
Ryan, D;
Sadeghirad, B;
Samolinski, B;
Schmid-Grendelmeier, P;
Sheikh, A;
Togias, A;
Valero, A;
Valiulis, A;
Valovirta, E;
Ventresca, M;
Wallace, D;
Waserman, S;
Wickman, M;
Wiercioch, W;
Yepes-Nuñez, J. J;
Zhang, L;
Zhang, Y;
Zidarn, M;
Zuberbier, T;
Schünemann, H. J.
BACKGROUND: Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of life and school and work performance and is a frequent reason for office visits in general practice. Medical costs are large, but avoidable costs associated with lost work productivity are even larger than thos...
